🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/03/2010 | 36,34 | 37,25 | 36,29 | 36,55 | +0,63% | 2,65% | 16.215.914 |
| 19/03/2010 | 36,32 | 37,06 | 36,12 | 36,32 | -1,01% | 2,60% | 32.252.934 |
| 18/03/2010 | 36,33 | 36,70 | 36,15 | 36,69 | +0,97% | 1,52% | 13.097.275 |
| 17/03/2010 | 36,25 | 36,36 | 35,85 | 36,34 | +0,37% | 1,40% | 12.983.986 |
| 16/03/2010 | 36,04 | 36,26 | 35,69 | 36,20 | +0,50% | 1,59% | 19.187.937 |
| 15/03/2010 | 35,34 | 36,07 | 35,31 | 36,02 | +1,59% | 2,16% | 18.251.863 |
| 12/03/2010 | 35,35 | 35,50 | 35,05 | 35,46 | +0,76% | 1,27% | 17.172.738 |
| 11/03/2010 | 34,69 | 35,26 | 34,45 | 35,19 | +0,57% | 2,34% | 16.049.177 |
| 10/03/2010 | 35,26 | 35,38 | 34,83 | 34,99 | -1,00% | 1,57% | 20.357.505 |
| 09/03/2010 | 35,51 | 35,59 | 35,14 | 35,34 | -0,83% | 1,26% | 15.401.198 |
| 08/03/2010 | 35,77 | 35,82 | 35,41 | 35,64 | -0,37% | 1,15% | 12.625.570 |
| 05/03/2010 | 35,52 | 35,84 | 35,24 | 35,77 | +0,94% | 1,69% | 10.342.502 |
| 04/03/2010 | 35,58 | 35,67 | 35,19 | 35,44 | -0,19% | 1,34% | 12.421.839 |
| 03/03/2010 | 35,96 | 36,12 | 35,40 | 35,51 | -0,48% | 1,99% | 13.186.879 |
| 02/03/2010 | 35,86 | 35,96 | 35,61 | 35,68 | +0,32% | 0,98% | 12.842.402 |
| 01/03/2010 | 35,33 | 35,72 | 35,33 | 35,56 | +1,06% | 1,08% | 12.373.107 |
| 26/02/2010 | 35,02 | 35,36 | 34,77 | 35,19 | +0,85% | 1,69% | 13.800.483 |
| 25/02/2010 | 34,77 | 34,98 | 34,40 | 34,90 | -0,97% | 1,67% | 17.854.252 |
| 24/02/2010 | 35,02 | 35,34 | 34,61 | 35,24 | +1,15% | 2,10% | 17.913.988 |
| 23/02/2010 | 35,21 | 35,44 | 34,73 | 34,84 | -1,64% | 2,01% | 16.699.670 |
| 22/02/2010 | 36,13 | 36,13 | 34,92 | 35,42 | -0,99% | 3,33% | 18.421.115 |
| 19/02/2010 | 35,52 | 35,91 | 35,45 | 35,77 | +0,54% | 1,29% | 13.004.003 |
| 18/02/2010 | 35,57 | 35,78 | 35,33 | 35,58 | -0,13% | 1,26% | 12.942.590 |
| 17/02/2010 | 36,00 | 36,18 | 35,46 | 35,63 | -0,85% | 2,01% | 12.534.918 |
| 16/02/2010 | 35,99 | 36,43 | 35,55 | 35,94 | +2,00% | 2,44% | 21.768.951 |
| 12/02/2010 | 34,95 | 35,45 | 34,44 | 35,23 | +0,11% | 2,89% | 18.766.955 |
| 11/02/2010 | 34,56 | 35,31 | 34,23 | 35,19 | +1,88% | 3,12% | 15.123.478 |
| 10/02/2010 | 34,83 | 35,01 | 34,12 | 34,54 | -0,74% | 2,55% | 17.627.884 |
| 09/02/2010 | 35,24 | 35,47 | 34,66 | 34,80 | -0,33% | 2,30% | 17.965.864 |
| 08/02/2010 | 34,90 | 35,38 | 34,56 | 34,91 | -0,38% | 2,35% | 10.705.949 |